tiprankstipranks
Advertisement
Advertisement

RVMD Stock Latest News

Revolution Medicines begins treating patients in RASolute 303
The FlyRevolution Medicines begins treating patients in RASolute 303
3d ago
RVMD
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
PremiumCompany Announcements
Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors
6d ago
RVMD
SMMT
Revolution Medicines assumed with a Buy at Jefferies
PremiumThe Fly
Revolution Medicines assumed with a Buy at Jefferies
20d ago
RVMD
Daraxonrasib Poised to Become Pancreatic Cancer Standard of Care on Strong RASolute 302 Outlook and Accelerated Launch Path
PremiumRatings
Daraxonrasib Poised to Become Pancreatic Cancer Standard of Care on Strong RASolute 302 Outlook and Accelerated Launch Path
25d ago
RVMD
Erasca price target raised to $20 from $10 at Stifel
PremiumThe Fly
Erasca price target raised to $20 from $10 at Stifel
26d ago
ERAS
RVMD
Revolution Medicines Doubles Down on Costly RAS Push
PremiumCompany AnnouncementsRevolution Medicines Doubles Down on Costly RAS Push
1M ago
RVMD
Revolution Medicines put volume heavy and directionally bearish
Premium
The Fly
Revolution Medicines put volume heavy and directionally bearish
1M ago
RVMD
Revolution Medicines assumed with a Buy at UBS
Premium
The Fly
Revolution Medicines assumed with a Buy at UBS
1M ago
RVMD
Tango Therapeutics weakness an ‘over reaction,’ says Stifel
PremiumThe Fly
Tango Therapeutics weakness an ‘over reaction,’ says Stifel
1M ago
BMY
RVMD
Revolution Medicines price target lowered to $140 from $143 at Mizuho
PremiumThe Fly
Revolution Medicines price target lowered to $140 from $143 at Mizuho
1M ago
RVMD
Revolution Medicines price target raised to $120 from $75 at Piper Sandler
PremiumThe Fly
Revolution Medicines price target raised to $120 from $75 at Piper Sandler
1M ago
RVMD
Revolution Medicines price target raised to $115 from $109 at BofA
PremiumThe Fly
Revolution Medicines price target raised to $115 from $109 at BofA
1M ago
RVMD
Revolution Medicines price target raised to $144 from $100 at Wells Fargo
PremiumThe FlyRevolution Medicines price target raised to $144 from $100 at Wells Fargo
1M ago
RVMD
Revolution Medicines: Advancing RAS Inhibitor Pipeline and Strong Cash Runway Support Buy Rating
Premium
Ratings
Revolution Medicines: Advancing RAS Inhibitor Pipeline and Strong Cash Runway Support Buy Rating
1M ago
RVMD
Revolution Medicines reports Q4 EPS ($1.86), consensus ($1.56)
Premium
The Fly
Revolution Medicines reports Q4 EPS ($1.86), consensus ($1.56)
1M ago
RVMD
Revolution Medicines sees FY26 operating expenses $1.6B-$1.7B
PremiumThe Fly
Revolution Medicines sees FY26 operating expenses $1.6B-$1.7B
1M ago
RVMD
Revolution Medicines initiated with an Outperform at Evercore ISI
PremiumThe Fly
Revolution Medicines initiated with an Outperform at Evercore ISI
1M ago
RVMD
Is RVMD a Buy, Before Earnings?
PremiumPre-Earnings
Is RVMD a Buy, Before Earnings?
1M ago
RVMD
Revolution Medicines placed on ‘Positive Catalyst Watch’ at JPMorgan
PremiumThe Fly
Revolution Medicines placed on ‘Positive Catalyst Watch’ at JPMorgan
2M ago
RVMD
Revolution Medicines put volume heavy and directionally bearish
PremiumThe FlyRevolution Medicines put volume heavy and directionally bearish
2M ago
RVMD
Revolution Medicines price target raised to $122 from $92 at JPMorgan
Premium
The Fly
Revolution Medicines price target raised to $122 from $92 at JPMorgan
2M ago
RVMD
Revolution Medicines doses first patient in trial evaluating RMC-5127
Premium
The Fly
Revolution Medicines doses first patient in trial evaluating RMC-5127
2M ago
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >